Angiotensin-converting enzyme inhibition by enalapril: a novel approach to reduce ischemia/reperfusion damage after experimental liver transplantation. [electronic resource]
- Hepatology (Baltimore, Md.) Mar 1997
- 648-51 p. digital
Publication Type: Journal Article
0270-9139
10.1002/hep.510250326 doi
Angiotensin-Converting Enzyme Inhibitors--pharmacology Animals Enalapril--pharmacology Ischemia--prevention & control Liver--blood supply Liver Transplantation Male Microcirculation--drug effects Rats Rats, Inbred Lew Reperfusion Injury--prevention & control